Analysis by the ESTIMATE algorithm revealed that KIF2C expression was significantly positively correlated with immune and stromal scores in KIRC, LGG, and THCA, and significantly negatively correlated in GBM, LUSC, STAD, and UCEC, suggesting a possible role of KIF2C expression in tumor immunity and TME. This evidence concerns the gene KIF2C and glioblastoma.